Vident Investment Advisory, LLC Crispr Therapeutics Ag Transaction History

Vident Investment Advisory, LLC

$0
Q3 2023

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$43.47 - $67.77 $661,048 - $1.03 Million	-15,207 Reduced 63.49%	8,746 $491,000
Q1 2023 May 15, 2023	BUY	$41.0 - $56.12 $105,862 - $144,901	2,582 Added 12.08%	23,953 $1.08 Million
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $242,272 - $405,971	6,182 Added 40.7%	21,371 $868,000
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $152,444 - $209,031	2,495 Added 19.65%	15,189 $763,000
Q2 2022 Aug 15, 2022	SELL	$43.23 - $73.83 $179,923 - $307,280	-4,162 Reduced 24.69%	12,694 $769,000
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $112,869 - $168,147	2,122 Added 14.4%	16,856 $1.06 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $131,769 - $209,225	1,880 Added 14.63%	14,734 $1.12 Million
Q3 2021 Nov 12, 2021	SELL	$110.2 - $156.64 $152,516 - $216,789	-1,384 Reduced 9.72%	12,854 $1.44 Million
Q2 2021 Aug 13, 2021	BUY	$100.84 - $161.89 $256,536 - $411,848	2,544 Added 21.75%	14,238 $2.31 Million
Q1 2021 May 14, 2021	SELL	$110.72 - $210.04 $3,543 - $6,721	-32 Reduced 0.27%	11,694 $1.43 Million
Q4 2020 Feb 08, 2021	SELL	$79.67 - $173.23 $826,735 - $1.8 Million	-10,377 Reduced 46.95%	11,726 $1.8 Million
Q3 2020 Nov 12, 2020	SELL	$78.5 - $100.64 $64,291 - $82,424	-819 Reduced 3.57%	22,103 $1.85 Million
Q2 2020 Jul 17, 2020	SELL	$38.5 - $76.05 $2,579 - $5,095	-67 Reduced 0.29%	22,922 $1.68 Million
Q1 2020 May 12, 2020	SELL	$33.68 - $62.53 $19,096 - $35,454	-567 Reduced 2.41%	22,989 $975,000
Q4 2019 Feb 11, 2020	SELL	$36.68 - $73.13 $306,828 - $611,732	-8,365 Reduced 26.21%	23,556 $1.44 Million
Q3 2019 Nov 13, 2019	SELL	$40.99 - $52.56 $37,382 - $47,934	-912 Reduced 2.78%	31,921 $1.31 Million
Q2 2019 Aug 12, 2019	BUY	$35.45 - $48.2 $1.16 Million - $1.58 Million	32,833 New	32,833 $1.55 Million

Others Institutions Holding CRSP

# of Institutions

491

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$380 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$359 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$143 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$142 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$142 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Account